All posts by: Michael Zand

About Michael Zand

Athersys stem cell therapy disappoints in first efficacy trial in ulcerative … – MedCity News

MedCity NewsHalfway through its first large-scale efficacy trial, Athersys’s experimental stem cell therapy did not provide significant benefit to patients with moderate-to-severe ulcerative colitis. But there’s another tranche of data coming later this summer …Athersys Inc. stem cell therapy for bowel disease fails to show ‘meaningful …Crain’s Cleveland BusinessAthersys stem–cell therapy for bowel disease fails … Continue reading

2014-04-28 NEWS